Jin Zhang: Exploring Precision Treatment in Breast Cancer and Advances in Anti-HER2 Therapy – MediaMedic

MediaMedic shared a post on LinkedIn:

“2024 COMB丨Dr. Jin Zhang: Exploring Precision Treatment in Breast Cancer and Advances in Anti-HER2 Therapy

At the 7th Oncology Precision Diagnosis and Treatment Conference (COMB 2024), Dr. Jin Zhang from Tianjin Medical University Cancer Institute and Hospital led discussions on cutting-edge regional breast cancer management. The focus was on de-escalation in early-stage surgery and the evolving landscape of anti-HER2 therapy in advanced breast cancer.

Dr. Zhang’s insights highlight the promising strides in individualized treatment, reflecting a more precise approach to breast cancer care in China.”

Additional information

Source: MediaMedic/LinkedIn